In recognition of Endometrial Cancer Awareness Month, this episode features Jennifer Graham, a three-time cancer patient and patient advocate with the Marathon of Hope Cancer Centres Network (MOHCCN). Jennifer shares her experiences navigating breast, endometrial, and ovarian cancer, reflecting on the emotional realities of diagnosis, treatment, survivorship, and living with uncertainty. Together, we discuss the importance of support systems, how cancer shaped her perspective on life an...

In this episode of the GOSH Podcast’s Next Gen in 10 series, we are joined by Alison Luo, a Master’s student at the University of British Columbia supervised by Dr. Paul Yong. Alison discusses her research on pain sensitivity and central sensitization in endometriosis using clinical mechanical testing, as well as her work validating a prediction model for pain-related quality of life outcomes after endometriosis surgery. Together, we explore how better understanding pain processing may help i...

In recognition of Cancer Research Month 💜🎗️, we sit down with Dr. Barbara Vanderhyden to reflect on the origins and evolution of the Canadian Conference on Ovarian Cancer Research (CCOCR). What began as a small, ambitious idea in 2001 has grown into a national, multidisciplinary forum bringing together basic scientists, clinicians, epidemiologists, and psychosocial researchers from across Canada. In this episode, we discuss the importance of collaboration in advancing ovarian cancer research,...

🎙️ Next Gen in 10 is back! This episode features Arabella Helgason, a UBC Master’s student supervised by Dr. Aline Talhouk, whose research examines how endometrial cancer surveillance currently works for Lynch syndrome carriers — and how it might be improved. Using population data, Arabella is exploring surveillance patterns and investigating new approaches, including the potential role of self-sampling. 🎧 Tune in to learn how trainee research is helping rethink cancer surveillance. F...

New episode alert! 🎙️ How can we move beyond BMI to better understand endometrial cancer risk? In this episode, Dr. Aline Talhouk and Dr. Andrea Neilson discuss the RESTORE study and the use of the Progesterone Challenge Test (PCT) as a functional way to assess hormonal activity in the endometrium — and identify who may truly be at higher biological risk. We talk through the study design, as well as early findings showing strong feasibility and participant engagement. The conversation also ex...

Can we better predict who will benefit from endometriosis surgery? In this episode, Sabrina speaks with Dr. Dwayne Tucker about developing the Endometriosis Pain Index — a machine learning–based tool designed to help guide surgical decision-making and set realistic expectations for pain outcomes. From predictive modelling to patient-centred care, this conversation explores how data can transform how we approach endometriosis treatment. 🎧 Listen now wherever you get your podcasts. #Endometrios...

In this episode, Sabrina sits down with Dr. Jennifer Ritonja, a scientist in the Department of Population Health Sciences at the BC Cancer and epidemiologist specializing in modifiable risk factors for women’s cancers. Together, they explore what life-course research tells us about physical activity, body fatness, vitamin D, and the realistic potential of lifestyle-based prevention for ovarian cancer. Does timing matter? Is being active at one stage of adulthood enough? And how do we distingu...

How does contraceptive choice influence ovarian cancer risk? On this episode of the GOSH Podcast, we discuss BEACON, a five-year CIHR-funded research program examining the biologic and population-level links between contraception and ovarian cancer prevention. We are joined by Dr. David Huntsman, Dr. Gillian Hanley, and Dr. Laura Schummers, stepping in for Aim 3 Lead Dr. Wendy Norman, to explore how this interdisciplinary team is integrating molecular pathology, epidemiology, and health polic...

In this episode, we’re joined by Tessa Woodside, MSc student at UBC, whose research examines hormone therapy use and breast and endometrial cancer risk using large, real-world health data from BC and Alberta. Tessa walks us through her research questions, methods, early findings, and why the details of hormone therapy matter when we talk about cancer risk. 🎧 Tune in to hear how population-level data can answer questions clinical trials often can’t. For more information on the Gynecologic Canc...

New GOSH episode out now! 🎙️ On this episode, we are joined by Dr. Madeline Rhind, a medical oncology fellow at BC Cancer, to discuss her work on druggable targets and prognostic biomarkers in vulvar squamous cell carcinoma. The conversation highlights challenges in rare cancer research and the importance of translating molecular discoveries into clinical care. Tune in now at the link in our bio! #vulvarcancer #gynecancer #bccancer For more information on the Gynecologic Cancer Initiati...